Mylan, Teva Settle Over Generic Provigil Market Rights
Mylan Inc. has settled its dispute with Teva Pharmaceuticals USA Inc. concerning its suit against the U.S. Food and Drug Administration over allegations that Teva and subsidiary Cephalon Inc. worked to...To view the full article, register now.
Already a subscriber? Click here to view full article